EUVIMEDEUVIMED entdecken
Open Access

Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report

Lenka Ilcisin, Ruxu Han, Mark Krailo, David S Shulman, Brent R Weil, Christopher B Weldon, Puja Umaretiya, Rahela Aziz-Bose, Katie A Greenzang, Richard Gorlick, Damon R Reed, R Lor Randall und 5 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Lenka Ilcisin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical S…. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma, Poverty. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: St Baldrick's Foundation, National Clinical Trials Network (NCTN) Operations Center, NCTN Statistics & Data Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children living in poverty and those of marginalized race or ethnicity experience inferior disease outcomes across many cancers. Whether survival disparities exist in osteosarcoma is poorly defined. We investigated the association between race, ethnicity, and proxied poverty exposures and event-free and overall survival for children with nonmetastatic osteosarcoma receiving care on a cooperative group trial.

Methods

We conducted a retrospective cohort study of US patients with nonmetastatic, osteosarcoma aged 5-21 years enrolled on the Children’s Oncology Group trial AOST0331. Race and ethnicity were categorized to reflect historically marginalized populations, as Hispanic, non-Hispanic Black, non-Hispanic Other, and non-Hispanic White. Poverty was proxied at the household and neighborhood levels. Overall survival and event-free survival functions of time from trial enrollment were estimated using the Kaplan–Meier method. Hypotheses of associations between risks for event-free survival, death, and postrelapse death with race and ethnicity were assessed using log-rank tests.

Results

Among 758 patients, 25.6% were household-poverty and 28.5% neighborhood-poverty exposed. Of the patients, 21% of children identified as Hispanic, 15.4% non-Hispanic Black, 5.3% non-Hispanic Other, and 54.0% non-Hispanic White. Neither household or neighborhood poverty nor race and ethnicity were statistically significantly associated with risks for event-free survival or death. Postrelapse risk for death differed statistically significantly across race and ethnicity with non-Hispanic Black patients at greatest risk (4-year postrelapse survival 35.7% Hispanic vs 13.0% non-Hispanic Black vs 43.8% non-Hispanic Other vs 38.9% non-Hispanic White; P = .0046).

Conclusions

Neither proxied poverty exposures or race and ethnicity were associated with event-free survival or overall survival, suggesting equitable outcomes following frontline osteosarcoma trial-delivered therapy. Non-Hispanic Black children experienced statistically significant inferior postrelapse survival. Investigation of mechanisms underlying postrelapse disparities are paramount.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaPovertyAdolescentChildChild, PreschoolFemaleHumansMaleYoung AdultBlack or African AmericanEthnicityHispanic or LatinoRetrospective StudiesUnited StatesWhite

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
  • Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Children's Oncology Group, Monrovia, CA, USA.
  • Children's Oncology Group, Arcadia, CA, USA.
  • Department of Population and Public Health Sciences Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.

ORCID-Profile: Kira Bona

Förderung

  • St Baldrick's Foundation
  • National Clinical Trials Network (NCTN) Operations Center
  • NCTN Statistics & Data Center
  • NCI NIH HHS
  • National Clinical Trials Network
  • Operations Center
  • NIH

Zitieren

APA

Ilcisin, L., Han, R., Krailo, M., Shulman, D. S., Weil, B. R., Weldon, C. B., Umaretiya, P., Aziz-Bose, R., Greenzang, K. A., Gorlick, R., Reed, D. R., Randall, R. L., Nadel, H., Binitie, O., Dubois, S. G., Janeway, K. A., & Bona, K. (2024). Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae103

Vancouver

Ilcisin L, Han R, Krailo M, Shulman DS, Weil BR, Weldon CB, et al. Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae103

BibTeX
@article{Ilcisin2024,
  author = {Ilcisin, Lenka and Han, Ruxu and Krailo, Mark and Shulman, David S and Weil, Brent R and Weldon, Christopher B and Umaretiya, Puja and Aziz-Bose, Rahela and Greenzang, Katie A and Gorlick, Richard and Reed, Damon R and Randall, R Lor and Nadel, Helen and Binitie, Odion and Dubois, Steven G and Janeway, Katherine A and Bona, Kira},
  title = {Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae103}
}
Kostenlos starten →